Keros Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $565k | 8.5k | 66.17 |
| 2023-12-31 | $270k | 6.8k | 39.69 |
| 2023-09-30 | $547k | 17k | 31.87 |
| 2023-03-31 | $782k | 18k | 42.68 |
| 2022-12-31 | $392k | 8.2k | 47.96 |